港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫美概念股

951.843

+3.3210.35%

漲家數：5

跌家數：4

平家數：4

市盈率：- -

高：962.122

開：950.038

低：933.927

收：948.522

成交量：5,714.21萬

成交額：5.75億

市值：1,569.12億

流通市值：1,171.29億

資料載入中...

總覽新聞資訊

中國復星醫藥上半年淨利按年增1.2%，創新藥品與境外業務穩健增長

昊海生物科技(06826.HK)8月25日耗資19.62萬港元回購1.2萬股

【券商聚焦】中信建投：醫療器械板塊估值正在重構

昊海生物科技(06826)8月24日斥資393.9萬港元回購24.96萬股

瑞麗醫美(02135)股價顯著下跌14.286%，現價港幣$0.102

阿斯达克财经

醫美板塊整體承壓時代天使（06699）跌2.53%、四環醫藥（00460）跌2.29%

《業績》昊海生物科技(06826.HK)中期純利1.13億人民幣跌46.6% 派息25分

阿斯达克财经

昊海生物科技(06826)將於10月16日派發中期股息每股0.25元

昊海生物科技(06826.HK)：田敏獲委任為授權代表

昊海生物科技(06826.HK)公布中期業績歸母淨利潤約1.13億元按年減少46.64%

港股午評|恒生指數早盤漲0.72% 鋰礦股漲幅居前

復星醫藥(02196.HK)治療HTG小核酸創新藥FXR0906完成中國I期臨床首例參與者給藥

阿斯达克财经

港股異動 | 三生製藥(01530)升逾7% 上半年經調整的經營性歸母淨利按年增長26.5%

三生製藥發布2026中期業績：創新驅動、合作共贏、行穩致遠

三生製藥(01530.HK)發布中期業績，股東應占溢利11.47億元按年減少15.58%

三生製藥(01530)出現大手買入46.15萬股，成交價$16.52，涉資762.398萬

阿斯达克财经

港股異動 | 四環醫藥(00460)升逾6% 上半年淨利預增不低於217.2% 公司醫美業務進入快速放量階段

復星醫藥(02196)股價上升8.483%，現價港幣$18.16

阿斯达克财经

港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%

老虎资讯综合

國家藥監局批准三生製藥非甾體抗炎藥上市

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BK1593/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":951.843,"timestamp":1787645292709,"preClose":948.5223,"halted":0,"volume":57142098,"delay":0,"changeRate":0.003501,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":3.32074,"latestTime":"08-25 16:00:00","open":950.0384,"high":962.1216,"low":933.9272,"amount":574625275,"amplitude":0.029725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"pbRate":1.204102,"peRate":11.218186,"turnoverRate":0.002762,"increases":5,"decrements":4,"flats":4,"marketCap":156912127448,"floatMarketCap":117129149144},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":962.1216,"amplitude":0.029725,"preClose":948.5223,"low":933.9272,"pbRate":"1.204102","latestPrice":951.843,"volume":57142098,"delay":0,"open":950.0384,"prevYearClose":1094.978,"prevWeekClose":957.756,"prevMonthClose":920.614,"prevQuarterClose":846.145,"fiveDayClose":944.095,"twentyDayClose":933.838,"sixtyDayClose":911.147,"secType":"PLATE","market":"HK","turnoverRate":0.002762,"peRate":11.218186,"marketCap":156912127448,"floatMarketCap":117129149144,"timestamp":1787645292709,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":5,"down":4,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662733637","title":"中國復星醫藥上半年淨利按年增1.2%，創新藥品與境外業務穩健增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733637","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733637?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 18:02","pubTimestamp":1787652146,"startTime":"0","endTime":"0","summary":"中国复星医药上半年净利同比增1.2%，创新药品与境外业务稳健增长路透北京8月25日-中国“复星系”医药及疫苗巨头--复星医药600196.SS2196.HK周二公布，上半年净利同比增1.2%，营收同比增4.8%，主要得益于创新药品与境外业务稳健增长。该公司在上交所刊登的财报显示，上半年实现净利17.2亿元人民币，营收204.4亿元；同期扣除非经常性损益的净利11.4亿元，同比增19.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4T44M0KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK0028","BK0175","BK0187","BK0239","BK0060","BK0196","BK1191","BK0183","BK0096","BK1593","02196","600196","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662780752","title":"昊海生物科技(06826.HK)8月25日耗資19.62萬港元回購1.2萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662780752","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662780752?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 17:27","pubTimestamp":1787650027,"startTime":"0","endTime":"0","summary":"格隆汇8月25日丨昊海生物科技(06826.HK)发布公告，2026年8月25日耗资19.62万港元回购1.2万股，回购价格每股16.3-16.49港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32346519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705207","title":"【券商聚焦】中信建投：醫療器械板塊估值正在重構","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705207","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705207?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:32","pubTimestamp":1787621521,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，建议2026年加配医疗器械板块，短期来看，建议把握2026年业绩改善个股的业绩和估值修复机会，高值耗材和IVD板块的集采或降价影响将于下半年逐步出清，多家细分赛道龙头将于2026年迎来加速增长，同时建议关注手术机器人、脑机接口等新科技方向，相关技术突破和商业化落地有望持续催化板块热度。长期来看，医疗器械板块投资机会来自创新、出海和并购整合，板块的创新和国际化能力得到认可，估值正在重构。风险提示：行业政策风险、研发不及预期风险、审批不及预期风险、宏观环境波动风险、中东地缘政治风险。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235","PTH","BK1189","BK1161","BK1571","BK0276","KCE","GDOC","BK1589","09996","MDEV","BK1584","BK1593","LGHT","01066","BK1247","BK1591","00853","RSPH","BK1615","LU0287142896.SGD","02252","02190","HK0000165453.HKD","LNGR","HART","IEIH","BK1600","AGNG","BK1617","01302","LU0173614495.USD","00241","BK1515","BK1610","MEDX","601066","BK1502","BK1585","BK1574","BK1501","BK1222","159883","BK1100","BK1583","BK1142","06826","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222503","title":"昊海生物科技(06826)8月24日斥資393.9萬港元回購24.96萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222503","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222503?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 17:25","pubTimestamp":1787563513,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年8月24日斥资393.9万港元回购24.96万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661223350","title":"瑞麗醫美(02135)股價顯著下跌14.286%，現價港幣$0.102","url":"https://stock-news.laohu8.com/highlight/detail?id=2661223350","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661223350?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 13:20","pubTimestamp":1787548800,"startTime":"0","endTime":"0","summary":"[下跌股]瑞丽医美(02135) 股价在下午01:19比前收市价显著下跌14.286%，现股价为港币$0.102。至目前为止，今日最高价为$0.102，而最低价为$0.102。总成交量为1万股，总成交金额为港币$1020。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608244288/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608244288/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1209","BK1593","02135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661473242","title":"醫美板塊整體承壓 時代天使（06699）跌2.53%、四環醫藥（00460）跌2.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661473242","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661473242?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 10:33","pubTimestamp":1787538824,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医美板块整体承压，截至发稿，昊海生物科技 跌5.16%，时代天使跌2.53%，复星医药跌2.30%，四环医药跌2.29%，山东新华制药股份跌1.37%，现代牙科跌1.22%。华龙证券新近研究指，企业层面，国内医美企业持续突破海外监管认证，海外市场有望成为重要增长第二曲线，行业高质量发展态势明确。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989117","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1593","02196","BK1600","00460","06699","06826","BK1583","BK1191","03600","BK1515","00719","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661248296","title":"《業績》昊海生物科技(06826.HK)中期純利1.13億人民幣跌46.6%  派息25分","url":"https://stock-news.laohu8.com/highlight/detail?id=2661248296","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661248296?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 19:34","pubTimestamp":1787484840,"startTime":"0","endTime":"0","summary":"昊海生物科技(06826.HK) 公布6月止六个月中期业绩，营业收入11.66亿人民币(下同)，按年下降9.8%。录得纯利1.13亿元，倒退46.6%，每股盈利49分。中期息25分，上年同期派40分。(d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/04/24第一季业绩无派息2026/03/20末期业绩股息：人民币 0.6000 (约相等于 0.688247 港元)2025/10/24第三季业绩无派息2025/08/22中期业绩股息：人民币 0.4000 (约相等于 0.438462 港元)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230627125933138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230627125933138_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540096/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540096/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["MCNHmain","MUCmain","BK1593","UCmain","BK1161","CNHmain","CYB","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293799","title":"昊海生物科技(06826)將於10月16日派發中期股息每股0.25元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293799?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:30","pubTimestamp":1787319039,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，该公司将于2026年10月16日派发中期股息每股0.25元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","VIG","BK4588","BK1161","BK1593","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661429323","title":"昊海生物科技(06826.HK)：田敏獲委任為授權代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2661429323","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661429323?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:25","pubTimestamp":1787318748,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293956","title":"昊海生物科技(06826.HK)公布中期業績 歸母淨利潤約1.13億元 按年減少46.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293956","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293956?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:15","pubTimestamp":1787318136,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661251291","title":"港股午評|恒生指數早盤漲0.72%     鋰礦股漲幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2661251291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661251291?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 12:00","pubTimestamp":1787284830,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.72%，涨184点；恒生科技指数指数涨0.50%；港股早盘成交1360亿港元。天齐锂业涨8.8%；赣锋锂业涨超7%。恒生指数公司将于今日公布第二季度指数评估结果。思格新能或加入港股通标的，涨超10%。恒基地产涨超6%领涨蓝筹。中期股东应占盈利40.9亿港元，同比增加40.65%。中软国际绩后涨超7%，上半年股东应占溢利3.5亿元，同比增加11%。金嗓子盈警后跌超21%，预计上半年纯利同比跌四成，受销售费用增加拖累。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252152.HKD","09115","LU0359201885.HKD","LU0173614495.USD","07300","02837","LU0737861699.HKD","03115","LU1770034418.SGD","HK0000914686.HKD","BK1593","LU0359202008.SGD","300750","02788","MCHmain","BK1601","LU0572940350.SGD","83115","LU0345781412.USD","BK1113","BK1594","LU0630314457.HKD","02800","00012","01378","01772","03423","BK1129","LU1719994722.HKD","BK1207","002460","LU1152091754.HKD","00354","513600","LU1152091168.USD","BK1568","BK1526","LU0307460666.USD","03750","LU0572939691.SGD","HSTECH","LU1807302812.USD","LU1960683339.HKD","HK0000286598.CNH","BK1506","LU1023057109.AUD","LU1808992512.USD","LU0210526637.USD","07500","HK0000500386.USD","SG9999014674.SGD","BK1511","LU1224709979.USD","SG9999001093.SGD","LU1303224171.USD","07552","BK1559","BK1190","HK0000252160.HKD","HK0001040168.HKD","BK1610","BK1592","LU1993786604.SGD","06656","02600","LU2279858448.HKD","BK1589","SG9999003461.SGD","03417","LU0051755006.USD","06869","LU0287142896.SGD","LU0345780950.USD","LU1251922891.USD","06896","002466","03067","09696","HK0000914660.USD","03032","BK1518","LU0456827905.SGD","LU0469268626.HKD","BK1522","BK1175","03419","601869","BK1240","09088","82800","03088","LU0067412154.USD","09067","601600","LU0264606111.USD","BK1117","02706","BK1586","LU1166156734.SGD","LU1171460220.USD","HHImain","03033","SG9999006597.SGD","01866","BK1543","LU0359201612.USD","HK0001040143.USD","BK1500","BK1509","BK1170","BK1116","HLDCY","01530","BK1523","HSI","BK1161","BK1155","03037","LU0880133367.SGD","07200","00189","BK1149","HK0000165453.HKD","02833","LU0588546209.SGD","LU1008478684.HKD","BK1513","07226","BK1583","LU0702159699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661225995","title":"復星醫藥(02196.HK)治療HTG小核酸創新藥FXR0906完成中國I期臨床首例參與者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2661225995","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661225995?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 10:35","pubTimestamp":1787279700,"startTime":"0","endTime":"0","summary":"复星医药宣布，用于治疗高甘油三酯血症的肝靶向siRNA小干扰核酸创新药FXR0906注射液，于近日在中国境内完成I期临床首例参与者给药。FXR0906由复星医药集团许可引进，并享有该药品于中国内地及港澳地区研究、开发、注册、生产及商业化的独占权利。截至目前，中国境内尚无用于治疗高甘油三酯血症的小干扰核酸药物获批上市。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1539809/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1539809/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0012","BK0060","BK1593","BK1191","BK0183","BK0239","BK0175","BK1574","BK0028","BK0187","600196","159992","BK0096","BK0196","06978","02196","BK0188","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661598772","title":"港股異動 | 三生製藥(01530)升逾7% 上半年經調整的經營性歸母淨利按年增長26.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661598772","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661598772?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 10:22","pubTimestamp":1787278953,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药(01530)涨超7%，截至发稿，涨6.85%，报17.63港元，成交额3.95亿港元。消息面上，三生制药发布2026年中期业绩。上半年公司实现营业收入45.3亿元，同比增长3.9%；归母净利润11.5亿元，同比减少15.58%；经调整的经营性归母净利润14.4亿元，同比增长26.5%。上半年核心品种获全球23个国家上市许可，海外产品销售同比增长43%，来源于公司rhEPO、益赛普、rhTPO等品种在全球多个新兴经济体国家提升市场渗透率。集团预期于可预见未来人民币汇率波动对经营并无重大不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK1583","01530","BK1593","HK0000165453.HKD","BK1161","BK4585","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233703","title":"三生製藥發布2026中期業績：創新驅動、合作共贏、行穩致遠","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233703","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233703?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 23:17","pubTimestamp":1787239022,"startTime":"0","endTime":"0","summary":"三生制药今日发布2026年中期业绩公告。今年上半年，公司实现营业收入45.3亿元，同比增长3.9%，归母净利润11.5亿元，经调整的经营性归母净利润14.4亿元，同比增长26.5%，研发费用6.8亿元，同比增长24.9%，公司财务资源194亿元，充裕的资金储备为研发投入和战略布局提供了坚实保障。上半年核心品种获全球23个国家上市许可，海外产品销售同比增长43%，来源于公司rhEPO、益赛普、rhTPO等品种在全球多个新兴经济体国家提升市场渗透率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260820/32341912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","BK1593","BK1161","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238133","title":"三生製藥(01530.HK)發布中期業績，股東應占溢利11.47億元 按年減少15.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238133","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660238133?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 22:33","pubTimestamp":1787236399,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404750","title":"三生製藥(01530)出現大手買入46.15萬股，成交價$16.52，涉資762.398萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404750","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404750?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:59","pubTimestamp":1787212740,"startTime":"0","endTime":"0","summary":"[大手成交]三生制药(01530)在下午03:59出现大手买入，成交量为46.15万，成交价为港币$16.52，涉资762.398万。至目前为止，股价跌1.019%，今日最高价为$17.85，而最低价为$16.34，总成交量为5.623千万股，总成交金额港币$9.607亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608206016/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608206016/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530","HK0000165453.HKD","BK1161","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660406619","title":"港股異動 | 四環醫藥(00460)升逾6% 上半年淨利預增不低於217.2% 公司醫美業務進入快速放量階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2660406619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660406619?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 14:18","pubTimestamp":1787206705,"startTime":"0","endTime":"0","summary":"消息面上，近期，四环医药业绩盈喜预告，集团预期于截至2026年6月30日止六个月取得收入不低于人民币11.4亿元，与去年同期大致持平；取得期内净利润不低于人民币2.1亿元，较去年同期增长不低于217.2%。该行认为，公司医美业务进入快速放量阶段，创新药及其他药品、仿制药业务盈利有望改善，公司经营拐点已至。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1515","KCAI","BK1191","BK4585","BK4588","BK1593","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660477052","title":"復星醫藥(02196)股價上升8.483%，現價港幣$18.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2660477052","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660477052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:33","pubTimestamp":1787193180,"startTime":"0","endTime":"0","summary":"[上升股]复星医药(02196) 股价在上午10:33比前收市价上升8.483%，现股价为港币$18.16。至目前为止，今日最高价为$18.16，而最低价为$17.42。总成交量为597.604万股，总成交金额为港币$1.069亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202496/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202496/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["600196","BK1515","BK0060","BK1191","BK0175","BK0239","BK1593","BK0196","BK0028","BK0183","02196","BK0012","BK0188","BK0187","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162366260","title":"港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162366260","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162366260?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:59","pubTimestamp":1787191169,"startTime":"0","endTime":"0","summary":"8月20日，港股创新药概念股集体走强，$中国生物制药(01177)$涨超20%，$石药集团(01093)$涨超16%，$晶泰控股(02228)$、$金斯瑞生物科技(01548)$涨超12%，$乐普生物(02157)$、$康方生物(09926)$涨超11%，$荣昌生物(09995)$、$复星医药(02196)$涨超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1191","LU2399975544.HKD","BK1583","LU0880133367.SGD","LNGR","LU0315179316.USD","LU0417516738.SGD","LU1993786604.SGD","IBBQ","LU0540923850.HKD","LU0561508036.HKD","LU1794554557.SGD","BK1617","BK1521","LU0348827113.USD","LU1226288253.USD","LU2778985437.USD","LU1226287529.USD","LU0326950275.SGD","06978","02196","LU2476274720.SGD","LU2476274308.USD","IE00BZ08YR35.GBP","HK0000306685.HKD","09926","IE00B5MMRT66.SGD","159992","LU1152091168.USD","VXUS","IE00B543WZ88.USD","LU0348783233.USD","LU1152091754.HKD","LU1813983027.USD","LU0348825331.USD","BK1161","HK0000320223.HKD","LU0140636845.USD","LU0348735423.USD","SG9999004220.SGD","LU1951186391.HKD","HK0000306701.USD","IE0008368742.USD","BK1141","IE00BZ08YS42.EUR","09995","LU0501845795.SGD","LU1807302812.USD","KCAI","LU1969619763.USD","BK1574","LU0348784397.USD","BK1515","BK1593","IE0008369823.USD","02228","LU0348766576.USD","LU2039709279.SGD","IE00B031HY20.USD","HK0000165453.HKD","LU1008478684.HKD","LU0417516902.SGD","LU0072913022.USD","01548","KURE","LU0348767384.USD","MEDX","LU0314109678.HKD","01177","LU0417516571.SGD","LU1226287875.USD","LU1328277881.USD","01093","LU1226288170.HKD","BK1589","LU2488822045.USD","IE00BPRC5H50.USD","LU1720050803.USD","LU1960683339.HKD","LU0067412154.USD","LU2328871848.SGD","LU1961090484.USD","BK1576","LU1226287792.SGD","HK0000320264.USD","02157","LU0634319403.HKD","IE00BZ08YT58.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153271973","title":"國家藥監局批准三生製藥非甾體抗炎藥上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1153271973","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153271973?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:59","pubTimestamp":1787191149,"startTime":"0","endTime":"0","summary":"国家药品监督管理局正式批准了三生制药旗下非甾体抗炎药物的上市申请。这一决定标志着该药物在完成严格的临床研究与审评流程后，获得了进入中国市场的通行证。值得注意的是，非甾体抗炎药作为临床常用的镇痛消炎类药物，其市场潜力与治疗价值备受关注。业内人士指出，该药物的获批将进一步增强三生制药在抗炎镇痛领域的竞争力。三生制药方面表示，将持续致力于高质量药物的研发与生产，以满足未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1161","BK1593","HK0000165453.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":43,"code":"91000000","status":"200"}]}}